Q4 2013 13F Holders as of 31 Dec 2013
-
Type / Class
-
Equity / Common Stock par value $0.012 per share
-
Shares outstanding
-
39,608,807
-
Total 13F shares
-
863,848
-
Share change
-
0
-
Total reported value
-
$13,329,430
-
Price per share
-
$15.43
-
Number of holders
-
13
Institutional Holders of ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share (ORMP) as of Q4 2013
As of 31 Dec 2013,
ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share (ORMP) was held by
13 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
863,848 shares.
The largest 10 holders included
MARXE AUSTIN W & GREENHOUSE DAVID M, GREYLIN INVESTMENT MANGEMENT INC, MORGAN STANLEY, FineMark National Bank & Trust, UBS AG, WELLS FARGO & COMPANY/MN, GLENMEDE TRUST CO NA, Highlander Capital Management, LLC, FIRST NEW YORK SECURITIES LLC /NY, and HABERER REGISTERED INVESTMENT ADVISOR INC.
This page lists
13
institutional shareholders reporting positions in this security
for the Q4 2013 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.